Monty K. Allen - Dec 7, 2024 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ Monty K. Allen
Stock symbol
IRMD
Transactions as of
Dec 7, 2024
Transactions value $
$0
Form type
4
Date filed
12/10/2024, 09:00 PM
Previous filing
Jun 4, 2024
Next filing
Dec 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +1.75K +9.7% 19.8K Dec 7, 2024 Direct F1
transaction IRMD Common Stock Options Exercise +1.2K +6.04% 21K Dec 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1.75K -100% $0.00 0 Dec 7, 2024 Common Stock 1.75K Direct F1, F2
transaction IRMD Restricted Stock Units Options Exercise $0 -1.2K -49.98% $0.00 1.2K Dec 7, 2024 Common Stock 1.2K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3 On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.